/ Print /

Health Management

Genetic testing in oncology: 5 things payers should knowAs genomics continues to evolve, here are five things to know about genetic testing and counseling.
Five ways healthcare executives can better support physiciansA survey explores how physicians perceive their role in the healthcare system, and the findings aren’t good.
Four ways health execs can prep for costly CAR-T cell therapiesWith the high efficacy and dire diagnosis, there will be demand for both Kymriah and Yescarta. Here’s how to manage the monetary impact.
Study: Formularies may be key to alleviating opioid epidemicNew Yale University research offers stunning findings about drug formulary coverage and prescribing opioids.
Program uses provider, patient incentives to fight opioid epidemicProviders are coming up short when it comes to HEDIS measures related to substance abuse. Here’s how one health plan is changing that.
Top strategy plans, providers can use to motivate member behavior changesAs the healthcare system shifts from a focus on employee-based plans to consumer-based plans, insurers have to find new ways to engage and motivate members.
Medicare Advantage vs. specialized Medicare Advantage plans: Outcome effectsAvalere Health analysis has intriguing results about beneficiaries enrolled in diabetes-focused chronic condition special needs plans.
FDA challenges abuse-deterrent opioid drug claimThe FDA pushes back on new painkiller’s abuse-deterrent claims. Here’s why this is important to the opioid epidemic.
This is why you should be excited for upcoming cancer researchAcute myeloid leukemia experts share promising new developments on the oncology horizon.
Study: Patients combine toxic medications with ‘alarming frequency’A new study uses population health analytics to identify potential opioid abuse, and the study findings are troubling.